Survival Effects of Cytoreductive Surgery for Refractory Patients after Neoadjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer.
WonKyo ShinJoseph J NohSang-Soo SeoSokbom KangChel Hun ChoiSang-Yoon ParkByoung Gie KimMyong Cheol LimPublished in: Yonsei medical journal (2020)
CRS may result in a survival benefit even in patients with AEOC who develop PD after NAC.
Keyphrases
- neoadjuvant chemotherapy
- end stage renal disease
- locally advanced
- ejection fraction
- minimally invasive
- newly diagnosed
- lymph node
- chronic kidney disease
- transcription factor
- sentinel lymph node
- prognostic factors
- coronary artery bypass
- patient reported outcomes
- early stage
- radiation therapy
- rectal cancer
- patient reported